Viridian Therapeutics, Inc.\DE (VRDN) Accumulated Depreciation (2016 - 2019)

Historic Accumulated Depreciation for Viridian Therapeutics, Inc.\DE (VRDN) over the last 5 years, with Q1 2019 value amounting to $3.2 million.

  • Viridian Therapeutics, Inc.\DE's Accumulated Depreciation changed N/A to $3.2 million in Q1 2019 from the same period last year, while for Mar 2019 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $3.1 million for FY2018, which is N/A changed from last year.
  • Viridian Therapeutics, Inc.\DE's Accumulated Depreciation amounted to $3.2 million in Q1 2019.
  • Viridian Therapeutics, Inc.\DE's 5-year Accumulated Depreciation high stood at $3.2 million for Q1 2019, and its period low was $600000.0 during Q1 2015.
  • Moreover, its 4-year median value for Accumulated Depreciation was $786000.0 (2016), whereas its average is $1.3 million.
  • Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Accumulated Depreciation surged by 3372.86% in 2015 and then surged by 2731.21% in 2016.
  • Over the past 4 years, Viridian Therapeutics, Inc.\DE's Accumulated Depreciation (Quarter) stood at $739000.0 in 2015, then grew by 19.22% to $881000.0 in 2016, then soared by 250.74% to $3.1 million in 2018, then grew by 2.23% to $3.2 million in 2019.
  • Its Accumulated Depreciation was $3.2 million in Q1 2019, compared to $3.1 million in Q4 2018 and $881000.0 in Q3 2016.